Exane Derivatives’s SmileDirectClub, Inc. Class A Common Stock SDC Stock Holding History

Exane Derivatives’s Portfolio SDC Stock Details SDC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-11,000	Closed	-$151K	–	743
2019 Q4	$151K	Buy	+11,000	New	+$110K	0.03%	277

Other funds holding SDC

CDR

Clayton Dubilier & Rice New York $536M AUM 0.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

MVP

Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return

IIC

Integrated Investment Consultants Bloomfield Hills, Michigan $471M AUM 20.31% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Exane Derivatives's SDC Position: Q1 2020 in Review

Exane Derivatives sold out of SmileDirectClub, Inc. Class A Common Stock (SDC) in Q1 2020, closing a stake of 11,000 shares — an estimated $151K sold.

Exane Derivatives first reported a position in SDC in Q4 2019 and held it in 1 quarter. The position peaked at $151K in Q4 2019. 133 funds tracked by Wall St. Rank hold SDC as of Q1 2020.

Exane Derivatives reported no remaining SmileDirectClub, Inc. Class A Common Stock position as of Q1 2020 after selling out during the quarter.
Exane Derivatives sold 11,000 SmileDirectClub, Inc. Class A Common Stock shares in Q1 2020, an estimated $151K.
Exane Derivatives first reported a position in SmileDirectClub, Inc. Class A Common Stock in Q4 2019 and held it in 1 quarter.
Exane Derivatives's SmileDirectClub, Inc. Class A Common Stock position peaked at $151K in Q4 2019.
133 funds tracked by Wall St. Rank held SmileDirectClub, Inc. Class A Common Stock as of Q1 2020.

Based on Exane Derivatives's 13F filing for Q1 2020, filed 17 Apr 2020.